Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 18, 2019

SELL
$35.43 - $56.29 $35 - $56
-1 Closed
0 $0
Q3 2018

Oct 11, 2018

SELL
$44.22 - $75.47 $406,558 - $693,871
-9,194 Reduced 99.99%
1 $0
Q2 2018

Aug 09, 2018

BUY
$72.38 - $92.5 $184,930 - $236,337
2,555 Added 38.48%
9,195 $734,000
Q1 2018

Apr 11, 2018

BUY
$69.46 - $88.57 $87,866 - $112,041
1,265 Added 23.53%
6,640 $575,000
Q4 2017

Feb 07, 2018

BUY
$65.94 - $93.31 $73,589 - $104,133
1,116 Added 26.2%
5,375 $371,000
Q3 2017

Oct 16, 2017

BUY
$80.87 - $91.08 $344,425 - $387,909
4,259
4,259 $387,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.